Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
Titel:
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
Auteur:
Ramanathan, Ramesh K. Von Hoff, Daniel D. Eskens, Ferry Blumenschein, George Richards, Donald Genvresse, Isabelle Reschke, Susanne Granvil, Camille Skubala, Adam Peña, Carol Mross, Klaus